Past
The Commission on Cancer (CoC) was established in 1922 to set comprehensive standards for cancer care, and accreditation is achieved by meeting stringent quality-based endpoints.1 Approximately 1500 out of 5200 community hospitals are CoC accredited (29%).2
However, the impact of CoC accreditation on survival in a variety of types of solid-organ cancers has not been systematically evaluated.
Present
Ahmed et al.3 found that CoC-accreditation is an independent predictor of 2-year survival for 5/59 solid organ cancers (primary sites in lung and bronchus, liver, esophagus, pancreas, and intrahepatic bile duct), but does not exhibit statistical significance in other solid-organ cancers. On stage-by-stage analysis in these five cancers, accreditation significantly increases survival. This trend is maintained during multivariate analysis (0.86–0.91 hazard ratios, all p values < 0.005), but CoC-accreditation status was not the most important predictor of survival and was on average below both cancer stage and patient age.
Future
These results may suggest that accreditation impacts survival only in a small subset of complex cancers. Future studies are required to verify our findings in the long-term. Accreditation standards focusing on type-specific cancer outcome metrics could yield further improvements in outcome. For example, adherence to criteria by the National Accreditation Program for Rectal Cancer has been found to correlate with significant improvements in survival.4 Additionally, the effect of accreditation on several other relevant oncological metrics, such as recurrence, disease-free survival, and quality-of-life, require further investigation for a variety of cancers.
References
Standards and Resources. ACS. https://www.facs.org/quality-programs/cancer-programs/commission-on-cancer/standards-and-resources/. Accessed 5 Jan 2023.
Fast Facts on U.S. Hospitals, 2022. 2023. https://www.aha.org/statistics/fast-facts-us-hospitals. Accessed 26 May 2023.
Ahmed A, Whittington J, Shafaee Z. Impact of commission on cancer accreditation on cancer survival: a SEER database analysis. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14709-4.
Brady JT, Bingmer K, Bliggenstorfer J, et al. Could meeting the standards of the National Accreditation Program for rectal cancer in the National Cancer Database improve patient outcomes? Colorectal Dis. 2023;25(5):916–22. https://doi.org/10.1111/codi.16503.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors do not have anything to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article refers to: Ahmed A, Whittington J, Shafaee Z. Impact of Commission on Cancer accreditation on cancer survival: A SEER database analysis. Annals Surgical Oncology. Ann Surg Oncol (2023). https://doi.org/10.1245/s10434-023-14709-4.
Rights and permissions
About this article
Cite this article
Ahmed, A., Whittington, J. & Shafaee, Z. ASO Author Reflections: Commission on Cancer Accreditation as an Independent Predictor of Cancer Survival. Ann Surg Oncol 31, 2303 (2024). https://doi.org/10.1245/s10434-023-14824-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14824-2